Skip to main content
Earnings Labs
Kyverna Therapeutics, Inc. logo

Kyverna Therapeutics, Inc. (KYTX)

NASDAQ·Healthcare·Biotechnology

$8.17

+3.16%

Mkt Cap $356.90M

Analyst Ratings

Buy

4

Hold

0

Sell

0

Price Target (7 analysts)

$30.75

Range $25.00$33.00

Implied Upside

+276.4%

Consensus $30.75 vs current $8.17